External Neurostimulation Device Market
External Neurostimulation Device Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
External
Neurostimulation Device Market Size and Growth
The external neurostimulation device market is experiencing notable growth, driven by rising incidences of neurological disorders and technological advancements. The market size is projected to reach approximately $4 billion by 2025, with increasing demand for non-invasive treatment options fostering innovation and expanding applications across various healthcare sectors.
Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Medtronic (US)
◍ Boston Scientific (US)
◍ Abbott Laboratories (US)
◍ LivaNova (UK)
◍ Baxter (US)
◍ AxoGen (US)
◍ Stryker (US)
The external neurostimulation device market features key players like Medtronic, Boston Scientific, Abbott Laboratories, LivaNova, Baxter, AxoGen, and Stryker, which drive growth through innovative product development and strategic partnerships. Notable sales revenues include Medtronic's $30 billion (2022), Abbott's $43 billion (2021), and Boston Scientific's $11 billion (2022).
Request Sample Report
Market Segmentation
By Application
◍ Hospitals and Clinics
◍ Ambulatory Surgery Center
By Product
◍ Transcutaneous Electrical Nerve Stimulation
◍ Transcranial Magnetic Stimulation
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
